sglt2 inhibitors vs glp-1 agonists Cardiorenal Protection: Potential of and Receptor in the Treatment of Type 2 Diabetes | Diabetes Therapy Use of GLP-1 Receptor Agonists
Description
The Source: This story was written with information provided by Gallup
Discussions with individual employers suggest that some have stopped covering these medications for weight loss, with a few even tightening up coverage for those with diabetes, according to the report
( [Google Scholar] 14.Cummins E The Future of Weight Loss Looks a Lot Like Its Past
Herman GA, Stein PP, Thornberry NA, Wagner JA
doi: 10.1126/science.adj2537
Protein intake and lean mass Preserving muscle should be a priority, not an afterthought
